Hif1 Beta Subunit
Hif1 Beta Subunit - Related Videos
02:25
An Assay for Analyzing Test β-Glucan as an Immunotherapy Strategy against Brain Cancer Cells
0 Views •
2025
This video demonstrates an in vitro assay utilizing β-glucans to activate microglial cells for the production of superoxide radicals, a reactive oxygen species. In brain cancer cells, the generated reactive oxidants actively suppress tumor cell proliferation and induce cell death.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
09:36
Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
0 Views •
Cited by 7 •
2017
This publication presents a protocol showing how to measure the activity of recombinant protein phosphatase 2A catalytic subunit (PP2Ac) in response to recombinant α-synuclein, β-synuclein, or γ-synuclein proteins using a simple colorimetric assay. We show findings regarding α-synuclein specificity toward PP2Ac in mouse brain.
06:09
In Vitro Reassociation Assay to Measure the Formation of 80S Ribosomal Particles Using Salt-washed Ribosomal Subunits
0 Views •
2025
Here, we describe a detailed protocol for the in vitro reassociation of purified, salt-washed eukaryotic ribosomal subunits for the analysis of 80S particle formation. This method is illustrated by analyzing ribosomal subunits isolated from a wild-type strain of Saccharomyces cerevisiae and a mutant strain deficient in the ribosomal protein eL24.
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
0 Views •
Cited by 3 •
2013
Structure-based drug design plays an important role in drug development. Pursuing multiple targets in parallel greatly increases the chance of success for lead discovery. The following article highlights how the Seattle Structural Genomics Center for Infectious Disease utilizes a multi-target approach for gene-to-structure determination of the PB2 influenza A subunit.
FAQs
Constitutive expression keeps HIF-1 beta available as a potential partner when oxygen conditions change. This distinguishes it from a response that would require producing the subunit only after hypoxia begins. Consequently, regulation can depend on formation and activity of the HIF-1 alpha-containing complex, helping connect oxygen availability with coordinated gene expression.
The basic helix-loop-helix and PAS domains are central structural features of the subunit. Together, they support the protein interactions needed for dimerization with HIF-1 alpha and for the resulting complex to engage DNA at hypoxia-response elements. Their presence therefore links molecular assembly with transcriptional regulation during low-oxygen conditions.
Unlike the constitutively expressed beta subunit, HIF-1 alpha supplies the oxygen-responsive counterpart described in the hypoxic complex. This division of roles matters because beta provides a recurring dimerization partner, whereas the alpha-containing complex forms under low-oxygen conditions. Studying both components clarifies how oxygen sensing becomes coordinated gene regulation.
Binding to hypoxia-response elements gives the HIF-1 complex a route to control specific genes rather than producing a nonspecific cellular reaction. The regulated outputs include angiogenesis, glucose metabolism, and cellular adaptation to low oxygen. Examining these target-gene effects helps connect DNA binding with physiological changes associated with oxygen homeostasis.
Research on HIF-1 beta extends beyond oxygen sensing itself because disrupted oxygen regulation affects several biological settings. The overview identifies development, cancer biology, and ischemic disease as important contexts. In each, examining this subunit can help relate altered HIF-1 signaling to changes in vascular growth, metabolism, or cellular adaptation under low-oxygen conditions.
Studies can ask whether changes in dimerization with HIF-1 alpha alter binding of the complex to hypoxia-response elements and activation of specific genes. Researchers can then relate those transcriptional changes to angiogenesis, glucose metabolism, and adaptation to low oxygen. This framework connects molecular observations to broader biological outcomes without treating oxygen response as a single process.